232 related articles for article (PubMed ID: 11655049)
21. Informed consent: defining limits through therapeutic parameters.
Daar JF
Whittier Law Rev; 1995; 16(1):187-209. PubMed ID: 11660487
[No Abstract] [Full Text] [Related]
22. Sacred or for sale? The human body in the age of biotechnology.
Andrews L; Kevorkian J; Kimbrell A; May WF; Hitt J
Harpers (N Y N Y); 1990 Oct; 281(1685):47-55. PubMed ID: 11654932
[No Abstract] [Full Text] [Related]
23. Human tissue research: who owns the results?
Wagner AB
J Pat Trademark Off Soc; 1987 Jun; 69(6):329-52. PubMed ID: 11649984
[No Abstract] [Full Text] [Related]
24. Moore v. Regents of the University of California: patients, property rights, and public policy.
Biagi KG
St Louis Univ Law J; 1991; 35(2):433-62. PubMed ID: 16144099
[No Abstract] [Full Text] [Related]
25. Profiting from patient tissue: can patients lay claim to profits from products derived from their tissues?
Med World News; 1985 Jun; 26(11):63. PubMed ID: 11645555
[No Abstract] [Full Text] [Related]
26. Genetic information and property theory.
Barrad CM
Northwest Univ Law Rev; 1993; 87(3):1037-86. PubMed ID: 11656395
[No Abstract] [Full Text] [Related]
27. Living tissue and organ donors and property law: more on Moore.
Dickens BM
J Contemp Health Law Policy; 1992; 8():73-93. PubMed ID: 10183665
[No Abstract] [Full Text] [Related]
28. Patient autonomy and biomedical research: judicial compromise in Moore v. Regents of the University of California.
LoBiondo AR
Albany Law J Sci Technol; 1991; 1():277-305. PubMed ID: 16281328
[No Abstract] [Full Text] [Related]
29. Property rights and payment to patients for cell lines derived from human tissues: an economic analysis.
Greenberg W; Kamin D
Soc Sci Med; 1993 Apr; 36(8):1071-6. PubMed ID: 8475423
[TBL] [Abstract][Full Text] [Related]
30. Source compensation for tissues and cells used in biotechnical research: why a source shouldn't share in the profits.
Dillon TP
Notre Dame Law Rev; 1989; 64(4):628-45. PubMed ID: 11650898
[No Abstract] [Full Text] [Related]
31. Owning our bodies: an examination of property law and biotechnology.
Gold R
San Diego Law Rev; 1995; 32(4):1167-247. PubMed ID: 11656846
[No Abstract] [Full Text] [Related]
32. Cells, sales, and royalties: the patient's right to a portion of the profits.
Danforth MT
Yale Law Policy Rev; 1988; 6(1):179-202. PubMed ID: 11650242
[No Abstract] [Full Text] [Related]
33. Whose tissues are they anyway? A proposal for state ownership of the human body and its parts.
Schoenfeld MR
J Cardiovasc Diagn Proced; 1994-1995; 12(3):145-9. PubMed ID: 11654296
[No Abstract] [Full Text] [Related]
34. An institutional policy on the right to benefit from the commercialization of human biological material.
Prentice ED; Wiltse JC; Sharp JG; Antonson DL
Law Med Health Care; 1990; 18(1-2):162-7. PubMed ID: 2374448
[No Abstract] [Full Text] [Related]
35. Who owns the body? On the ethics of using human tissues for commercial purposes.
Murray TH
IRB; 1986; 8(1):1-5. PubMed ID: 11649702
[No Abstract] [Full Text] [Related]
36. Prospecting for genetic gold: compensating genetic research donors.
Triber GA
J Biolaw Bus; 1998; 2(1):20-8. PubMed ID: 11657635
[No Abstract] [Full Text] [Related]
37. Recognizing property interests in bodily tissues. A need for legislative guidance.
Parker PM
J Leg Med; 1989 Jun; 10(2):357-75. PubMed ID: 2760536
[No Abstract] [Full Text] [Related]
38. A disputed spleen.
Brahams D
Lancet; 1988 Nov; 2(8620):1151-2. PubMed ID: 2903372
[TBL] [Abstract][Full Text] [Related]
39. Ethical considerations in informed consent for potential future use of human tissue samples.
Adams M; Prentice ED; Oki GS
IRB; 1996; 18(2):6-7. PubMed ID: 11654756
[No Abstract] [Full Text] [Related]
40. Homo economicus: commercialization of body tissue in the age of biotechnology.
Nelkin D; Andrews L
Hastings Cent Rep; 1998; 28(5):30-9. PubMed ID: 11656768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
